Breast Imaging Market Size, Growth, Outlook, Demand, Key player Analysis and Opportunity till 2026

According to IMARC Group's latest report, titled "Breast Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global breast imaging market reached a value of US$ 3.70 Billion in 2020. Looking forward, the market is expected to reach US$ 6.1 Billion by 2026, growing at a CAGR of 8.70% during 2021-2026.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request a Free PDF Sample of the Report: https://www.imarcgroup.com/breast-imaging-market/requestsample

Breast imaging refers to the technique of diagnosing breast cancer through high-resolution images of breast tissues in both males and females. It involves numerous ionizing and non-ionizing technologies to screen, detect, and diagnose the type of cancer, its location, and stage of progression. It also utilizes various imaging procedures, such as screening mammography and breast ultrasound, to check for suspicious tissues and the surrounding auxiliary tissues for the early diagnosis of cancer before the actual symptoms appear.

Market Trends and Drivers:

The growing incidences of breast cancer are primarily driving the global breast imaging market. Besides this, the increasing awareness regarding the early detection of breast cancer and related diseases is also contributing to the market growth. Furthermore, the World Health Organization (WHO) has identified breast cancer as one of the most prevalent forms of cancer among women. As a result, governments worldwide are taking initiatives and preventive measures to mitigate the risk factors and enhance cancer screening and diagnosis. For instance, the Government of the United Kingdom has launched the "Be clear on cancer" program, which focuses on the early diagnosis of cancer. This has led to a significant rise in the adoption rate of breast imaging procedures across the globe. Moreover, extensive investments in advanced imaging software and hybrid systems, such as automated whole breast ultrasound systems (AWBU) and MBI/BSGI, are also facilitating market growth.

Breast Imaging Market 2021-2026 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the global breast imaging market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

Canon Inc.
Koninklijke Philips N.V
Toshiba Corporation
Siemens Healthineers AG (Cerner Corporation)
GE Healthcare
Allengers Medical Systems Limited.
Carestream Health Inc. (Onex Corporation)
Delphinus Medical Technologies
Dilon Technologies Inc.
Aurora Health Care Inc. (Schoen Clinic)

Key Market Segmentation:

The report has segmented the global breast imaging market on the basis of technology, end-user and region.

Breakup by Technology:

Ionizing Breast Imaging
Mammography
Positron Emission Tomography-Computed Tomography
Molecular Breast Imaging
Positron Emission Mammography
Cone-Beam Computed Tomography
Non-Ionizing Breast Imaging
Breast Ultrasound
Breast MRI
Automated Whole-Breast Ultrasound
Breast Thermography
Electric Impedance Tomography
Optical Imaging

Breakup by End-User:

Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Others

Breakup by Region:

North America
Asia Pacific
Europe
Latin America
Middle East and Africa

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2147&flag=C

Key Highlights of the Report:

Market Performance (2015-2020)
Market Outlook (2021-2026)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

This release was published on openPR.